ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round

November 20, 1981

“Proof Of Concept” Shown In Early Trial Of PKC-412

December 27, 2002

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981